Encouraging Results in Young Children With MPSIIIA Following Intraparenchymal AAV Gene Therapy
Time: 1:30 pm
day: Clinical Stream Day 2 PM
Details:
- Delving into viral vector developments including the use of antibodies for facilitative transportation across the blood brain barrier
- Going beyond AAVs for neurological gene therapies
- Aiding in your viral vector selection with a greater understanding of choices
